Friess Associates LLC Astrazeneca PLC Transaction History

Friess Associates LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$37.79 - $51.33 $15.8 Million - $21.5 Million	-418,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $559,200 - $625,200	15,000 Added 3.72%	418,000 $17.3 Million
Q1 2019 May 15, 2019	SELL	$35.49 - $43.02 $38,648 - $46,848	-1,089 Reduced 0.27%	403,000 $16.3 Million
Q4 2018 Feb 14, 2019	BUY	$36.86 - $41.49 $14.9 Million - $16.8 Million	404,089 New	404,089 $15.3 Million

1,334

476M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $218B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Friess Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Friess Associates LLC with notifications on news.